CAM
TYRA icon

Cormorant Asset Management’s Tyra Biosciences TYRA Stock Holding History

Cormorant Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-743,988
Closed -$6.54M – 76
2022
Q3 		$6.54M Hold
743,988
– – 0.46% 48
2022
Q2 		$5.32M Sell
743,988
-13,444
-2% -$107K 0.4% 52
2022
Q1 		$8.11M Sell
757,432
-82,500
-10% -$979K 0.62% 45
2021
Q4 		$11.6M Sell
839,932
-230,000
-21% -$4.57M 0.69% 39
2021
Q3 		$18.2M Buy
+1,069,932
New +$20.4M 0.74% 38

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cormorant Asset Management's TYRA Position: Q4 2022 in Review

Cormorant Asset Management sold out of Tyra Biosciences (TYRA) in Q4 2022, closing a stake of 743,988 shares — an estimated $6.54M sold.

Cormorant Asset Management first reported a position in TYRA in Q3 2021 and held it in 5 quarters. The position peaked at $18.2M in Q3 2021. 46 funds tracked by Wall St. Rank hold TYRA as of Q4 2022.

  • Cormorant Asset Management reported no remaining Tyra Biosciences position as of Q4 2022 after selling out during the quarter.
  • Cormorant Asset Management sold 743,988 Tyra Biosciences shares in Q4 2022, an estimated $6.54M.
  • Cormorant Asset Management first reported a position in Tyra Biosciences in Q3 2021 and held it in 5 quarters.
  • Cormorant Asset Management's Tyra Biosciences position peaked at $18.2M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2022.

Based on Cormorant Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.